ProQR Therapeutics N.V.
Last updated September 27, 2026
Organization details
- Legal name
- ProQR Therapeutics N.V.
- Ownership
- Public
- Status
- Active
- Headquarters country
- Netherlands
- Ticker symbol
- PRQR
- Primary stock exchange
- Nasdaq
Identifiers
- SEC CIK
- 0001612940
Board of directors
-
Alison Frances Lawton · DirectorSince 2026
-
Bart Filius · DirectorSince 2026
-
Begona Carreno-Gomez · DirectorSince 2026
-
Boer Daniel Anton De · Director · Chief Executive OfficerSince 2026
-
Domenico Valerio · DirectorSince 2026
-
Gerardus Johannes Platenburg · Director · Chief Scientific OfficerSince 2026
-
Gylvin Lykke Hinsch · DirectorSince 2026
-
James Samuel Shannon · DirectorSince 2026
-
Martin Alexander Maier · DirectorSince 2026
-
Theresa Heggie · DirectorSince 2026
Chief executives
Boer Daniel Anton De
· Chief Executive Officer
Since March 2026
Board connections
3 of this board's directors also sit on 6 other boards.
- via Theresa Heggie
- via Alison Frances Lawton
- via James Samuel Shannon
- via Alison Frances Lawton
- via Alison Frances Lawton
- via James Samuel Shannon
Insider trades
All notable trades →From SEC Forms 4 and 5. Open-market purchases and sales are highlighted; grants, option exercises and shares withheld for tax are routine.
- Bought, last 12 months
- $1,342,385
- 5 purchases by 2 insiders
- Sold, last 12 months
- $0
- 0 sales by 0 insiders
| Date | Insider | Transaction | Shares | Price | Value |
|---|---|---|---|---|---|
| Jul 31, 2026 | Boer Daniel Anton De Director, Officer (Chief Executive Officer) | Open-market purchase | +200,000 | $1.77 | $353,960 |
| Jul 17, 2026 | Bart Filius Director | Open-market purchase | +150,000 | $1.72 | $257,925 |
| Jul 9, 2026 | Boer Daniel Anton De Director, Officer (Chief Executive Officer) | Open-market purchase | +150,000 | $1.74 | $261,000 |
| Jul 7, 2026 | Boer Daniel Anton De Director, Officer (Chief Executive Officer) | Open-market purchase | +150,000 | $1.59 | $238,500 |
| Jun 26, 2026 | Bart Filius Director | Open-market purchase | +150,000 | $1.54 | $231,000 |
Reviews (0)
Sign in to write a review.
No reviews yet. Be the first to write one.